HomeCZMWF • OTCMKTS
add
Carl Zeiss Meditec AG
Previous close
$61.22
Year range
$61.21 - $133.53
Market cap
5.24B EUR
Avg Volume
78.00
P/E ratio
-
Dividend yield
-
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 539.34M | 0.79% |
Operating expense | 238.78M | 11.27% |
Net income | 34.13M | -62.96% |
Net profit margin | 6.33 | -63.24% |
Earnings per share | 0.43 | — |
EBITDA | 60.11M | -43.58% |
Effective tax rate | 32.31% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.34M | 24.06% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 2.11B | — |
Shares outstanding | 89.74M | — |
Price to book | 2.62 | — |
Return on assets | — | — |
Return on capital | 6.08% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 34.13M | -62.96% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Carl Zeiss Meditec AG is a multinational medical technology company and subsidiary of Carl Zeiss AG. It manufactures tools for eye examinations and medical lasers as well as solutions for neurosurgery, dentistry, gynecology and oncology. Among its products are the most common tools used by ophthalmologists and optometrists.
In October 2018, Carl Zeiss Meditec won FDA premarket approval for its ReLEx Smile laser system.
Also in October 2018, Carl Zeiss Meditec announced the acquisition of Reno, Nevada-based IanTech for an undisclosed sum.
In September 2019, Carl Zeiss Meditec launched the CIRRUS 6000 at the European Society of Retina Specialists 2019 Congress. Wikipedia
CEO
Founded
2002
Headquarters
Employees
4,950
